Holen Sie sich die Stockscreener-App
24.66
0.04%
0.01
Handel nachbörslich:
24.74
0.08
+0.32%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit - Yahoo! Finance Canada
Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea - GlobeNewswire Inc.
Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight - MarketScreener
Why Pfizer Can Still Prevail in the Obesity Fight With Novo NordiskWSJ - The Wall Street Journal
AMD, Uber, Pfizer earnings on deck; ADP job data: What to Watch - Yahoo Finance
ACQUISITIONS & MERGERS NEWS: Pfizer sues Metsera and Novo Nordisk to halt their proposed merger - VitalLaw.com
Pfizer sues to block Novo Nordisk’s “cynical” startup acquisition - Global Competition Review
Pfizer Hits Novo Nordisk In Fed. Court Over $9B Metsera Deal - Law360
Pfizer Sues Novo, Metsera for Second Time in Brewing Deal War - Bloomberg.com
Pfizer Reports Earnings on Tuesday. What to Expect. - Barron's
Pfizer files second lawsuit against Metsera, Novo Nordisk - Global Banking | Finance | Review
Stock Movers: Cisco, Disney, Pfizer - Bloomberg.com
Pfizer Lawsuits Allege Novo Nordisk’s Bid to Buy Obesity Biotech Metsera is Anticompetitive, Illegal - MedCity News
Pfizer Files Lawsuits Against Metsera and Novo Nordisk - Pharmaceutical Executive
Market Voices: Pfizer-Novo Nordisk legal battle; Trump on Zhao pardon - Seeking Alpha
Pfizer sues to block Novo Nordisk bid for obesity drug maker Metsera - The Business Journals
Did Novo Nordisk Just Say "Checkmate" to Pfizer? - Yahoo Finance
Metsera, Inc. Responds to Pfizer’s Litigation Claims - TipRanks
Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo - Investor's Business Daily
Metsera rejects Pfizer litigation as attempt to lower acquisition price - Investing.com
Pfizer sues Novo, Metsera for second time in brewing deal war - Crain's New York Business
Metsera issues statement regarding Pfizer litigation and proposed acquisition By Investing.com - Investing.com UK
Pfizer Q3 Earnings Preview: Results to test recovery hopes amid TrumpRx deal, Metsera dispute (PFE:NYSE) - Seeking Alpha
Pfizer Files Antitrust Suit to Block Novo Nordisk Acquisition of Metsera - The Wall Street Journal
Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera - Barron's
Pfizer Files Antitrust Lawsuit Against Metsera, Its Controlling Stockholders And Novo Nordisk - Nasdaq
Jim Cramer on Pfizer: “We’ll Find Out if Pfizer’s Going to Be More of a Stock and Less of a Bond Equivalent” - MSN
Metsera to address Pfizer's litigation in court - MarketScreener
Pfizer files second lawsuit against Metsera, Novo Nordisk By Reuters - Investing.com
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook - ts2.tech
Pfizer (PFE) Files Lawsuit Against Novo Nordisk Over Metsera Bid - GuruFocus
Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle - Benzinga
Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid - Financial Times
Pfizer sues Novo Nordisk and Metsera once againbid considered to restrict competition - MarketScreener
Pfizer files second lawsuit in fight over Metsera - Axios
United States Vitiligo Forecast Report 2025: A $320+ Million Market by 2033 Featuring Incyte, BMS, Clinuvel Pharmaceuticals, Astellas Pharma, Baxter, Pfizer, Dr. Reddy's LaboratoriesResearchAndMarkets.com - Business Wire
How To Earn $500 A Month From Pfizer Stock Ahead Of Q3 Earnings - Benzinga
Pfizer files fresh US lawsuit against Novo Nordisk bid for Metsera - MLex
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk - Caledonian Record
Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war - Yahoo Finance
Pfizer Inc. $PFE Shares Purchased by Machina Capital S.A.S. - MarketBeat
Intellectus Partners LLC Sells 32,016 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Gains Early FTC Clearance for Metsera Acquisition - Zacks Investment Research
Torray Investment Partners LLC Raises Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Sues To Block Metsera’s Move Toward Novo Nordisk Deal - Finimize
Metsera, Inc. Responds to Pfizer Litigation - TradingView
Pfizer Inc. $PFE Shares Sold by TIAA Trust National Association - MarketBeat
United States Multiple Myeloma Market Research Report 2025-2033, Profiles of Key PlayersNovartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, Takeda, and Bristol-Myers Squibb - Yahoo Finance
Meet the 7% Yield Dividend Stock That Could Soar in 2026 - Yahoo Finance
1 Incredible Reason to Buy Pfizer Stock (PFE) in November - Yahoo Finance
U.S. Vasopressin Market Poised for Transformation with - openPR.com
The Battle For Metsera Acquisition Heats Up As Pfizer Files A Second Lawsuit - Stocktwits
Pfizer sues Novo Nordisk and Metsera - MarketScreener
Pfizer (PFE) Sues Over Metsera Acquisition Bid - GuruFocus
Pfizer sues Metsera, Novo Nordisk to block rival bid - Seeking Alpha
Pfizer (PFE) Q3 Earnings: What To Expect - Yahoo Finance
Key facts: Pfizer to report Q3 earnings on Nov 4; faces legal battle over Metsera - TradingView
Palantir, AMD, Pfizer, Robinhood, McDonald’s, and Many More Stocks to Watch This Week - Barron's
1.89%
1.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):